Clinical trial
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients
NCT00002311 · Mucos Pharma GmbH and Co, Industry · Completed
Key facts
| NCT number | NCT00002311 |
|---|---|
| Title | The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients |
| Official title | A Phase I-II Dose Escalation Study to Examine the Safety of Four Doses of Wobenzym in HIV Seropositive Patients |
| Lead sponsor | Mucos Pharma GmbH and Co, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Wobenzym |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: